What is Lytle?
Based in Pasadena, California, Lytle serves as a premier provider of advanced oral and maxillofacial surgical solutions. Under the leadership of Dr. Christopher Chan, a board-certified specialist, the practice has carved out a distinct market position by integrating high-precision dental implant procedures with comprehensive oral surgery offerings. The center distinguishes itself through a commitment to patient-centric care, utilizing state-of-the-art diagnostic and surgical tools to perform complex interventions such as All-on-4 implants, bone grafting, and wisdom teeth extractions. Their focus on the San Gabriel Valley demographic underscores a robust regional strategy centered on clinical excellence and safety-first protocols.
How much funding has Lytle raised?
Lytle has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Lytle
PPP
Public-Private Partnership
What's next for Lytle?
With the recent capital deployment, Lytle is poised to enter a new phase of institutional growth. The strategic roadmap likely involves the expansion of its surgical facilities and the potential adoption of next-generation digital dentistry platforms to streamline patient workflows. As the firm transitions from a localized practice to a more scalable healthcare entity, the focus will remain on maintaining high-quality outcomes while optimizing operational efficiency. This late-stage financing provides the necessary runway to invest in advanced medical equipment and potentially broaden the scope of its specialized surgical services, ensuring the practice remains at the forefront of the oral surgery sector.
See full Lytle company page
